Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Predictive Role of Choline PET/CT on the Survival of Patients Affected by Prostate Cancer.

NCT06158178 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06158178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06158178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Predictive Role of Choline PET/CT on the Survival of Patients Affected by Prostate Cancer.
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Completed
Start date
August 8, 2017
Completion date
November 23, 2017
Enrollment
520 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer